Get started
Author

Angel M-L Chim

Observed names: A M-L Chim, A. Chim, A. M. ‐L. Chim, A. M.-L. Chim, A. M.‐L. CHIM, A. M.‐L. Chim, A.M. Chim, A.M.-L. Chim, A.M.L. Chim, Angel M. L. Chim, Angel M.-L. Chim, Angel M.‐L. Chim, Angel Mei-Ling Chim, Angel M‐L Chim
OpenAlex ID: A5113694736
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
2010 · Vincent Wai-Sun Wong, Grace Lai-Hung Wong, et al. · Gut · 657
Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B
2008 · H. L.‐Y. Chan, G. L.‐H. Wong, et al. · Journal of Viral Hepatitis · 404
Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease
2011 · V. W.-S. Wong, G. L.-H. Wong, et al. · Gut · 302
High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
2011 · V. W.-S. Wong, G. L.-H. Wong, et al. · Gut · 257
Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B
2008 · G L-H Wong, V W-S Wong, et al. · Gut · 235
Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B – a prospective cohort study with paired transient elastography examinations
2014 · G. L.‐H. Wong, H. L.‐Y. Chan, et al. · Alimentary Pharmacology & Therapeutics · 149
PDF
Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population
2010 · Grace L‐H Wong, Vincent W‐S Wong, et al. · Journal of Gastroenterology and Hepatology · 142
Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels
2008 · V. W.‐S. WONG, G. L.‐H. WONG, et al. · Alimentary Pharmacology & Therapeutics · 128
Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B
2009 · Grace L‐H Wong, Vincent W‐S Wong, et al. · Journal of Gastroenterology and Hepatology · 122
PNPLA 3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome
2014 · J. Shen, G. L.‐H. Wong, et al. · Alimentary Pharmacology & Therapeutics · 114
PDF
Prediction of off-Treatment Response to Lamivudine by Serum Hepatitis B Surface Antigen Quantification in Hepatitis B E Antigen-Negative Patients
2011 · Henry L-Y Chan, Grace L-H Wong, et al. · Antiviral Therapy · 108
Association of genetic variations with NAFLD in lean individuals
2021 · Huapeng Lin, Grace L.‐H. Wong, et al. · Liver International · 81
Assessment of non‐alcoholic fatty liver disease using serum total cell death and apoptosis markers
2012 · J. Shen, H. L.‐Y. Chan, et al. · Alimentary Pharmacology & Therapeutics · 78
Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HB e A g‐seroconversion in chronic hepatitis B patients at 3 years
2012 · G. L.‐H. Wong, V. W.‐S. Wong, et al. · Alimentary Pharmacology & Therapeutics · 54
PDF
Evaluation of Model for End-Stage Liver Disease for Prediction of Mortality in Decompensated Chronic Hepatitis B
2006 · Henry L-Y Chan, Angel M-L Chim, et al. · The American Journal of Gastroenterology · 46
Non-alcoholic fatty liver disease: Spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study
2013 · Jill M. Abrigo, Jiayun Shen, et al. · Journal of Hepatology · 41
Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir – A prospective study
2018 · Henry L. Y. Chan, Fiona W. S. Chan, et al. · Journal of Viral Hepatitis · 31
Serum interferon‐inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B
2015 · G. L.‐H. Wong, H. L.‐Y. Chan, et al. · Alimentary Pharmacology & Therapeutics · 31
PDF
Association of cytokine gene polymorphisms and liver fibrosis in chronic hepatitis B
2007 · Henry L‐Y Chan, Ada M‐L Tse, et al. · Journal of Gastroenterology and Hepatology · 25
Metabolic syndrome delays HB eAg seroclearance in Chinese patients with hepatitis B
2014 · J. C. Hsiang, G. L.‐H. Wong, et al. · Alimentary Pharmacology & Therapeutics · 22
Double‐blinded placebo‐controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B
2003 · H. L.‐Y. Chan, J. J.‐Y. Sung, et al. · Alimentary Pharmacology & Therapeutics · 22
PDF
A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg‐negative chronic hepatitis B in China
2008 · L. Zhu, C. ‐H. Tse, et al. · Journal of Viral Hepatitis · 16
Treatment of Patients with Chronic Hepatitis B who have Failed Previous Antiviral Treatment with Pegylated Interferon α2a (40 kDa; PEGASYS®)
2008 · Henry L-Y Chan, Vincent W-S Wong, et al. · Antiviral Therapy · 15
PDF
Genetic polymorphisms of interleukin‐1‐beta in association with sustained response to anti‐viral treatment in chronic hepatitis B in Chinese
2006 · H. L.‐Y. CHAN, A. M.‐L. TSE, et al. · Alimentary Pharmacology & Therapeutics · 15
Serum Hepatitis B Surface Antigen Kinetics in Severe Reactivation of Hepatitis B E Antigen Negative Chronic Hepatitis B Patients Receiving Nucleoside/Nucleotide Analogues
2013 · Grace L-H Wong, Henry L-Y Chan, et al. · Antiviral Therapy · 14
Works count: 36
Citation count: 3,127
H-index: 21
I10-index: 26
Year
Topic
Type